This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Methods Video S1. Mouse Positioning and Preparations for Cannulation The anesthetized mouse is positioned on the dissection tray. The mouse fur and skin are cut in a “U” shape. Mouse intestine and the rest of viscera are moved to the right and both the portal vein and vena cava are revealed. Steps: 7–10.
GUID: 1A76C85B-EABA-4927-9EC2-B9BBB657E355Methods Video S2. Liver Cannulation and Perfusion The inferior vena cava is cannulated and the liver is perfused to wash out blood and circulating cells as well as to eliminate calcium via EDTA. Steps: 11–15.
GUID: 244A1B19-B39E-4F68-9558-E717174A1A36Methods Video S3. Liver Digestion Collagenase (Liberase) is perfused to the liver to facilitate hepatocyte dispersion. Steps 16–19.
GUID: FB4C57A2-22BC-43D5-BC32-9F7DEEA268BBMethods Video S4. Liver Dissection The liver is dissected out gently by removing all connections to other organs. Step 20.
GUID: F225A9CA-2879-4E26-8FFA-6C9B0486416AMethods Video S5. Hepatocyte Purification The liver is removed to a 10 cm plate and is punctured repeatedly. Liver cells are released to the media and filtered. Steps 22–24.
GUID: 7B602D67-98E2-4165-8E3C-C8CEF958490BThis study did not generate any unique datasets or code.
Primary hepatocytes are a vital tool in various biomedical research disciplines, serving as an ex vivo model for liver physiology. Obtaining high yields of viable primary mouse hepatocytes is technically challenging, limiting their use. Here, we present an improved protocol based on the classic two-step collagenase perfusion technique. The liver is washed by perfusion, hepatocytes are dissociated by collagenase, separated from other cells, and cultured. This protocol was optimized to significantly reduce procedure duration and improve hepatocyte yield and viability.
Primary hepatocytes are a vital tool in various biomedical research disciplines, serving as an ex vivo model for liver physiology. Obtaining high yields of viable primary mouse hepatocytes is technically challenging, thereby limiting their use. Here, we present an improved protocol based on the classic two-step collagenase perfusion technique. The liver is washed by perfusion, hepatocytes are dissociated by collagenase, separated from other cells, and cultured. This protocol was optimized to significantly reduce procedure duration and improve hepatocyte yield and viability.
Timing: 20 min. (plus incubation for 4–16 h)
Note: Steps 1–4 should be done in sterile conditions, in a biological hood (i.e., biosafety cabinet)
Prepare cell culture plates; 12-well, 6-well, 10 cm, and 15 cm plates are suitable for hepatocyte plating.
Cover the bottom of the plates/wells with 0.01% rat-tail collagen solution. Incubate for 4–16 h at 37°C under sterile conditions (e.g., in a humidified CO2 incubator). Wash with PBS, aspirate PBS.Note: Lower diameter plates may be suitable but are less optimal due to decreased efficiency of cell dispersion across the well surface.
Note: Collagen-coated plates can be prepared days in advance provided they are stored under sterile conditions.
REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Chemicals, Peptides, and Recombinant Proteins | ||
HBSS with calcium, magnesium and phenol red | Biological industries | 02-015-1A |
HBSS no calcium, no magnesium and no phenol red | Biological industries | 02-018-1A |
EDTA (0.5 M) | Fisher bioreagents | BP2482-500 |
HEPES (1 M) | Sigma-Aldrich | H0887-100ML |
Ketamine (Clorketam) | Vetoquinol | 00 92297 43 082 |
Xylazine (Sedaxylan) | EuroVet | SEDAXYLAN |
DMEM low glucose | Biological industries | 01-050-1A |
Dulbecco's Phosphate Buffered Saline (DPBS) without calcium and magnesium | Biological industries | 02-023-1A |
Phosphate Buffered Saline (PBS) ×10 | Hylabs | BP507/500D |
L-Glutamine Solution | Biological industries | 03-020-1B |
Penicillin-Streptomycin Solution | Biological industries | 03-031-1B |
William's E Medium, no glutamine | Gibco | 12551-032 |
Fetal Bovine Serum (FBS) | Biological industries | 04-007-1A |
Collagen | Sigma-Aldrich | C3867-1VL |
Percoll | Santa Cruz biotechnologies | sc-500790A |
Trypan Blue Solution | Biological industries | 03-102-1B |
Liberase™ TM Research Grade | Sigma-Aldrich | 05401127001 |
Experimental Models: Organisms/Strains | ||
Mouse strain: C57BL/6JOlaHsd | Envigo | N/A |
Other | ||
Insulin syringe | Becton Dickinson (BD) | BD 324912 |
Cell strainer, 70 μm | Corning | CLS431751-50EA |
Cell lifter | Corning | CLS3008 |
Peristaltic pump | Gilson | Miniplus 3 PVC tubing 2.06 mm diameter |
Mouse dissection tray | N/A | N/A |
Water bath | N/A | N/A |
Sterile 50 mL centrifuge tubes | Corning | 430829 |
Sterile 25 mL serological pipettes | Bio-SORFA | 315100 |
27 gauge needle | BD Microlance | 302200 |
70% ethanol | N/A | N/A |
Head wearing magnifier eye loupe (optional) | N/A | N/A |
Collagen Solution (50 mL)
Reagent | Final Concentration | Stock Concentration |
---|---|---|
Collagen | 0.01%; 0.1 μg/mL | 100%; 1 mg/mL |
Sterile double deionized water (DDW) | - | - |
Total |
Note: Due to viscosity of collagen, we recommend doing a serial dilution (e.g., diluting collagen 1:100 and then diluting it again 1:100)
Reagent | Final Concentration | Stock Concentration | Volume (μL) |
---|---|---|---|
PBS | N/A | N/A | 40 |
Ketamine | 30 mg/mL | 100 mg/mL | 30 |
Xylazine | 6 mg/mL | 20 mg/mL | 30 |
Total | 100 |
Reagent | Final Concentration | Stock Concentration | Volume (mL) |
---|---|---|---|
HBSS no Ca 2+ no Mg 2+ no phenol red | - | - | 487 |
EDTA | 0.5 mM | 0.5 M | 0.5 |
HEPES | 25 mM | 1 M | 12.5 |
Total | 500 |
EGTA can be used as alternative to EDTA. We have found no difference in yield between the two chelating agents.
Reagent | Final Concentration | Stock Concentration | Volume (mL) |
---|---|---|---|
HBSS with Ca 2+ , Mg 2+ and phenol red | - | - | 487.5 |
HEPES | 25 mM | 1 M | 12.5 |
Total | 500 |
Note: The final pH at 37°C should be 7.4
Reagent | Final Concentration | Stock Concentration | Volume (mL) |
---|---|---|---|
Williams E media | - | - | 490 |
Glutamine | 1%; 2 mM | 100%; 200 mM | 5 |
Penicillin-Streptomycin Solution | 1% Pen-100 units/mL Strep-0.1 mg/mL | 100% Pen-10,000 units/mL Strep- 10 mg/mL | 5 |
Total | 500 |
Note: Many protocols add dexamethasone, insulin, transferrin and selenium to maintenance media. We found that this is not needed in short-term culturing. Importantly, these reagents profoundly affect hepatocyte biology (Batista et al., 2019; Goldstein et al., 2013; Lin et al., 2007; Weiller et al., 2004) and thus may affect experiment outcome.
Reagent | Final Concentration | Stock Concentration | Volume (mL) |
---|---|---|---|
DMEM low glucose | - | - | 470 |
FBS | 5% | 100% | 25 |
Penicillin-Streptomycin Solution | 1% Pen-100 units/ mL Strep-0.1 mg/ mL | 100% Pen-10,000 units/ mL Strep- 10 mg/ mL | 5 |
Total | 500 |
Liberase Stock Solution
Reagent | Concentration | Amount |
---|---|---|
Liberase | 1 mg/mL | 50 mg |
Digestion buffer | - | 50 mL |
Total | 50 mL |
The preparation of Liberase solution detailed here relates to preparation of stock concentration from powder. The stock is further diluted to a final concentration of 25 μg/mL during the procedure (step 5).
We found that Liberase, a specific type of collagenase is significantly more reproducible than other commercial collagenases.
Aliquot and store at −80°C. We have found that using aliquoted and frozen Liberase (with one or two freeze-thaw cycles) does not substantially affect enzyme activity (in contrast to other types of collagenase). Thus, there is no need to freshly prepare a Liberase solution.
Reagent | Final Concentration | Stock Concentration | Volume (mL) |
---|---|---|---|
Percoll | 90% | 100% | 9 |
PBSX10 | 1× | 10× | 1 |
Total | 10 |
Note: Percoll solution should be prepared fresh during the procedure.
This protocol is aimed at isolating hepatocytes from mouse liver. Following anesthesia, the vena cava is cannulated and the liver is perfused to chelate calcium and wash out blood. Then, collagenase is perfused to the liver in order to dissociate extracellular matrix. Finally, the liver is dissected and hepatocytes are purified by density-based separation. This protocol presents several advances over similar protocols (Berry and Friend, 1969; Casciano, 2000; Klaunig et al., 1981; Li et al., 2010; Renton et al., 1978; Seglen, 1976; Severgnini et al., 2012). The main improvements of this protocol are better reproducibility, shortened duration, reduced technical challenge, increased yield and higher viability. These are achieved by several steps we altered or optimized. For example: (a) We found that retrograde perfusion through the vena cava permits easier cannulation as opposed to portal vein cannulation. (b) Periodical clamping of the portal vein provides a visible checkpoint for proper perfusion and greatly facilitates efficient washing and digestion. (c) The type of collagenase used (Liberase) shows quicker digestion and better reproducibility compared to other collagenases. (d) Percoll-based density separation results in a population of purified hepatocytes of high viability. Some of these protocol improvements were already implemented in our previous publications (Goldstein et al., 2017a; Goldstein et al., 2017b) where we isolated hepatocytes for experiments demanding a high yield of cells (such as chromatin immunoprecipitation sequencing – ChIP-seq).
Here, the pump is washed and primed with perfusion buffer. The mouse is anesthetized and positioned on the dissection tray.
This section is shown in Methods Video S1.